Prognostic value of the syntax score in patients undergoing coronary artery bypass grafting for three‐vessel coronary artery disease
- 7 November 2008
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 73 (5) , 612-617
- https://doi.org/10.1002/ccd.21883
Abstract
Background: The Syntax score prognostic value has recently been highlighted in patients undergoing percutaneous coronary intervention (PCI) for multivessel coronary artery disease (CAD), however its prognostic value in patients undergoing coronary artery bypass grafting (CABG) for multivessel CAD is still unknown. The aim of this study was to evaluate the prognostic value of the Syntax score in patients undergoing CABG for 3‐vessel CAD. Methods: A cohort of 320 consecutive patients with multivessel (3‐vessel) CAD who were subjected for CABG were included in this study and divided into tertiles according to the Syntax score (34). During the 1‐year follow‐up, cardiovascular events including death, myocardial infarction (MI), and stroke were systematically indexed. The primary end point was the composite criteria death/MI/stroke. Results: The Syntax score ranged from 11–74 with a mean of 31.2 ± 12.6 and a median of 28.5 [22–38]. Baseline clinical characteristics were similar among the tertiles. No statistical difference was found for the composite criteria death/MI/stroke: 9.4% versus 7.5% versus 10.4% in the groups with a Syntax score 34, respectively (P = 0.754). Conclusion: Unlike for PCI, the Syntax score has a poor prognostic value for severe cardiovascular events in patients undergoing CABG for 3‐vessel CAD. Other risk scores should be used to predict the outcome of this population.Keywords
This publication has 30 references indexed in Scilit:
- The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery diseaseJournal of the American College of Cardiology, 2004
- Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trialThe Lancet, 2002
- Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trialJournal of the American College of Cardiology, 2001
- Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel DiseaseNew England Journal of Medicine, 2001
- Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERACI II): 30-day and one-year follow-up resultsJournal of the American College of Cardiology, 2001
- Comparison of Coronary Bypass Surgery with Angioplasty in Patients with Multivessel DiseaseNew England Journal of Medicine, 1996
- A Randomized Trial Comparing Coronary Angioplasty with Coronary Bypass SurgeryNew England Journal of Medicine, 1994
- A Randomized Study of Coronary Angioplasty Compared with Bypass Surgery in Patients with Symptomatic Multivessel Coronary DiseaseNew England Journal of Medicine, 1994
- Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): In-hospital results and 1-year follow-upJournal of the American College of Cardiology, 1993
- Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trialThe Lancet, 1993